These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25351721)

  • 1. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration.
    Khan GH; Galazis N; Docheva N; Layfield R; Atiomo W
    Hum Reprod; 2015 Jan; 30(1):133-48. PubMed ID: 25351721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic biomarkers of preterm birth risk in women with polycystic ovary syndrome (PCOS): a systematic review and biomarker database integration.
    Galazis N; Docheva N; Nicolaides KH; Atiomo W
    PLoS One; 2013; 8(1):e53801. PubMed ID: 23382852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review.
    Atiomo W; Khalid S; Parameshweran S; Houda M; Layfield R
    BJOG; 2009 Jan; 116(2):137-43. PubMed ID: 19076945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
    Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration.
    Galazis N; Olaleye O; Haoula Z; Layfield R; Atiomo W
    Fertil Steril; 2012 Dec; 98(6):1590-601.e1. PubMed ID: 22959458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure.
    Wu Y; Zhong G; Chen S; Zheng C; Liao D; Xie M
    Hum Reprod; 2017 Apr; 32(4):937-943. PubMed ID: 28333243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
    Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
    Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of circulating microRNAs miR-142-3p and miR-598-3p in women with polycystic ovary syndrome as potential diagnostic markers.
    Insenser M; Quintero A; de Lope S; Álvarez-Blasco F; Martínez-García MÁ; Luque-Ramírez M; Escobar-Morreale HF
    Hum Reprod; 2023 May; 38(5):951-960. PubMed ID: 36931262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental STAT3 signaling is activated in women with polycystic ovary syndrome.
    Maliqueo M; Sundström Poromaa I; Vanky E; Fornes R; Benrick A; Åkerud H; Stridsklev S; Labrie F; Jansson T; Stener-Victorin E
    Hum Reprod; 2015 Mar; 30(3):692-700. PubMed ID: 25609240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome.
    Galazis N; Afxentiou T; Xenophontos M; Diamanti-Kandarakis E; Atiomo W
    Eur J Endocrinol; 2013 Feb; 168(2):R33-43. PubMed ID: 23093701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.
    Willis GR; Connolly K; Ladell K; Davies TS; Guschina IA; Ramji D; Miners K; Price DA; Clayton A; James PE; Rees DA
    Hum Reprod; 2014 Dec; 29(12):2756-63. PubMed ID: 25336711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of smoking on pregnancy risks in women with polycystic ovary syndrome: a population-based study.
    Feferkorn I; Badeghiesh A; Mills G; Baghlaf H; Dahan M
    Hum Reprod; 2021 Aug; 36(9):2549-2557. PubMed ID: 34164665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in angiogenic potential of granulosa-lutein cells and follicular fluid contributes to luteal defects in polycystic ovary syndrome.
    Patil K; Hinduja I; Mukherjee S
    Hum Reprod; 2021 Mar; 36(4):1052-1064. PubMed ID: 33377483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of metformin treatment in vivo on acute and long-term energy metabolism and progesterone production in vitro by granulosa cells from women with polycystic ovary syndrome.
    Maruthini D; Harris SE; Barth JH; Balen AH; Campbell BK; Picton HM
    Hum Reprod; 2014 Oct; 29(10):2302-16. PubMed ID: 25139174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.